For informational purposes only — not investment advice

← Back to signals

INTC

LONGINSIDER BUYINSIDER SELLCONGRESS BUYCONGRESS SELL

INTEL CORP

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.

Funds
6
Score
6.06
vs SPY
+112.6%
Stock return (since Q-end)
+132.3%
SPY return (since Q-end)
+19.7%
Current price
$102.50
Days to cover (short int.)
1.0d↑+3.4%
as of 2026-07-31

News Summary

Positive

Intel delivered exceptional Q2 results with 25% revenue growth (fastest since 2011), beat EPS expectations by 2x ($0.42 vs $0.21), and secured major wins including Google's 3M+ TPU orders and NVIDIA foundry trials, positioning the company strongly in AI and custom chip manufacturing. However, the stock has suffered a sharp 28% decline in July from its peak despite fundamentals strength, and Intel faces near-term headwinds including flat PC sales guidance, aggressive CapEx spending plans, and ongoing restructuring layoffs that could pressure margins.

Red flags

  • Stock down ~28% in July despite strong earnings—potential valuation concern or market repricing of foundry execution risk
  • Flat PC sales guidance for Q3 2026 signals weakness in core Client Computing segment
  • Significant CapEx increase planned for foundry expansion—material cash burn and ROI uncertainty on capital-intensive foundry business model
  • Recent layoffs in DCAI group and multiple restructuring charges signal operational challenges despite revenue growth
  • 52-week volatility extreme ($19.60–$142.35 range) suggests elevated investor uncertainty despite government support

Funds Buying (6)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Maverick CapitalLee Ainslie3.0M+3.0M$132M1.5%NEW
Point72Steve Cohen2.9M+2.9M$130M0.2%NEW
Tiger GlobalChase Coleman1.6M+1.6M$72M0.3%NEW
Duquesne Family OfficeStanley Druckenmiller411K+411K$18M0.6%NEW
Glenview CapitalLarry Robbins400K+400K$18M0.5%NEW
Situational Awareness LPLeopold Aschenbrenner202K+202K$9M0.2%>+999%Existing

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where INTC ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Situational Awareness LP

position #20 of this fund's book

  1. 17SHARONAI HOLDINGS INC$18M
  2. 18PROPETRO HLDG CORP$13M
  3. 19VANECK ETF TRUST$10M
  4. 20INTEL CORP$9M
  5. 21TAIWAN SEMICONDUCTOR MANUFAC$8M
  6. 22HIVE DIGITAL TECHNOLOGIES LT$6M
  7. 23ASML HLDG NV N Y REGISTRY$6M
Maverick Capital

position #27 of this fund's book

  1. 24GFL ENVIRONMENTAL INC$161M
  2. 25DANAHER CORP DEL$155M
  3. 26ADVANCED MICRO DEVICES INC$138M
  4. 27INTEL CORP$132M
  5. 28CARVANA CO$132M
  6. 29SHERWIN WILLIAMS CO$126M
  7. 30ASTERA LABS INC$105M
Tiger Global

position #34 of this fund's book

  1. 31UNITEDHEALTH GROUP INC$95M
  2. 32EQUIPMENTSHARE COM INC$93M
  3. 33SHERWIN WILLIAMS CO$82M
  4. 34INTEL CORP$72M
  5. 35COSTAR GROUP INC$61M
  6. 36ATRENEW INC$46M
  7. 37ZILLOW GROUP INC$42M
Duquesne Family Office

position #37 of this fund's book

  1. 34Cleveland-Cliffs Inc New$20M
  2. 35Nuvation Bio Inc$19M
  3. 36Bloom Energy Corp$18M
  4. 37Intel Corp$18M
  5. 38Belite Bio Inc Sponsored$17M
  6. 39Protagonist Therapeutics Inc$17M
  7. 40Unity Software Inc$16M
Glenview Capital

position #38 of this fund's book

  1. 35DIGITALOCEAN HLDGS INC$21M
  2. 36BAKER HUGHES COMPANY$19M
  3. 37AKAMAI TECHNOLOGIES INC$18M
  4. 38INTEL CORP$18M
  5. 39BIOGEN INC$10M
  6. 40PRIMO BRANDS CORPORATION$10M

Values are quarter-end position sizes. Shown only for funds where INTC ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Signal History

QuarterDirectionFundsScorevs SPY
Q2 2026LONG68.11-36.1%
Q1 2026LONG66.06+112.6%

Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
TAN LIP BUCEOBUY105K$95.00$10.00M2026-08-11
Chandrasekaran NagasubramaniyanEVP, CT & Ops Off, GM FoundrySELL21K$118.28$2.49M2026-05-29
Miller Boise AprilEVP and Chief Legal OfficerSELL40K$99.53$4.01M2026-05-01

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
The Vanguard GroupSC 13G/A404.5M8.1%2026-01-30

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Shelley M CapitosenateSELL$1,001 - $15,0002026-07-212026-08-04
Matthew Robert Van EppshouseTN07SELL$1,001 - $15,0002026-06-162026-06-17
Nancy PelosihouseCA11BUY$1,000,001 - $5,000,0002026-05-292026-06-23
Alan ArmstrongsenateBUY$1,001 - $15,0002026-03-272026-07-21
Thomas H TubervillesenateSELL$100,001 - $250,0002024-05-132026-08-05
Thomas H TubervillesenateSELL$100,001 - $250,0002024-05-102026-08-05
Thomas H TubervillesenateBUY$50,001 - $100,0002024-05-092026-08-05
Thomas H TubervillesenateBUY$100,001 - $250,0002024-05-082026-08-05
Thomas H TubervillesenateBUY$100,001 - $250,0002024-05-072026-08-05

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.